These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 26735859)

  • 1. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
    Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis.
    Mangray S; Kelly DR; LeGuellec S; Fridman E; Aggarwal S; Shago M; Matoso A; Madison R; Pramanik S; Zhong S; Li R; Lombardo KA; Cramer S; Pressey J; Ross JS; Corona RJ; Bratslavsky G; Argani P; Coindre JM; Somers GR; Ali SM; Yakirevich E
    Am J Surg Pathol; 2018 Oct; 42(10):1360-1369. PubMed ID: 29901569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.
    Antonescu CR; Owosho AA; Zhang L; Chen S; Deniz K; Huryn JM; Kao YC; Huang SC; Singer S; Tap W; Schaefer IM; Fletcher CD
    Am J Surg Pathol; 2017 Jul; 41(7):941-949. PubMed ID: 28346326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
    Shon W; Sukov WR; Jenkins SM; Folpe AL
    Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
    Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
    Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma.
    Sugita S; Arai Y; Aoyama T; Asanuma H; Mukai W; Hama N; Emori M; Shibata T; Hasegawa T
    Hum Pathol; 2017 Jul; 65():225-230. PubMed ID: 28188754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
    Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR
    Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
    Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall.
    Kojima N; Arai Y; Satomi K; Kubo T; Matsushita Y; Mori T; Matsushita H; Ushijima T; Yatabe Y; Shibata T; Yonemori K; Ichimura K; Ichikawa H; Kawai A; Yoshida A
    Mod Pathol; 2022 Oct; 35(10):1439-1448. PubMed ID: 35440765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.
    Cornejo KM; Deng A; Wu H; Cosar EF; Khan A; St Cyr M; Tomaszewicz K; Dresser K; O'Donnell P; Hutchinson L
    Hum Pathol; 2015 Jun; 46(6):868-75. PubMed ID: 25864386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.
    Kunze K; Spieker T; Gamerdinger U; Nau K; Berger J; Dreyer T; Sindermann JR; Hoffmeier A; Gattenlöhner S; Bräuninger A
    Cancer Res; 2014 Nov; 74(21):6173-83. PubMed ID: 25252913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIC-rearranged Sarcomas: A Study of 20 Cases and Comparisons With Ewing Sarcomas.
    Yoshida A; Goto K; Kodaira M; Kobayashi E; Kawamoto H; Mori T; Yoshimoto S; Endo O; Kodama N; Kushima R; Hiraoka N; Motoi T; Kawai A
    Am J Surg Pathol; 2016 Mar; 40(3):313-23. PubMed ID: 26685084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.
    Italiano A; Sung YS; Zhang L; Singer S; Maki RG; Coindre JM; Antonescu CR
    Genes Chromosomes Cancer; 2012 Mar; 51(3):207-18. PubMed ID: 22072439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
    Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
    Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
    Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
    Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas.
    Specht K; Zhang L; Sung YS; Nucci M; Dry S; Vaiyapuri S; Richter GH; Fletcher CD; Antonescu CR
    Am J Surg Pathol; 2016 Apr; 40(4):433-42. PubMed ID: 26752546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma.
    Sugita S; Arai Y; Tonooka A; Hama N; Totoki Y; Fujii T; Aoyama T; Asanuma H; Tsukahara T; Kaya M; Shibata T; Hasegawa T
    Am J Surg Pathol; 2014 Nov; 38(11):1571-6. PubMed ID: 25007147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes.
    Yamada Y; Kuda M; Kohashi K; Yamamoto H; Takemoto J; Ishii T; Iura K; Maekawa A; Bekki H; Ito T; Otsuka H; Kuroda M; Honda Y; Sumiyoshi S; Inoue T; Kinoshita N; Nishida A; Yamashita K; Ito I; Komune S; Taguchi T; Iwamoto Y; Oda Y
    Virchows Arch; 2017 Apr; 470(4):373-380. PubMed ID: 28197724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
    Murali R; Chandramohan R; Möller I; Scholz SL; Berger M; Huberman K; Viale A; Pirun M; Socci ND; Bouvier N; Bauer S; Artl M; Schilling B; Schimming T; Sucker A; Schwindenhammer B; Grabellus F; Speicher MR; Schaller J; Hillen U; Schadendorf D; Mentzel T; Cheng DT; Wiesner T; Griewank KG
    Oncotarget; 2015 Nov; 6(34):36041-52. PubMed ID: 26440310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.